Lexapro vs. Prozac: How They Compare and Where They Differ

Lexapro and Prozac are two of the most familiar antidepressant names, and people often want to know which one is better. Research doesn’t name a clear winner. On average, they seem to work about equally well.

Where they really differ is in how they behave in the body. Prozac lingers for weeks after the last dose, and it affects how the liver clears several other medications. Lexapro leaves the body much faster and has fewer of those interactions. This post walks through what that means in practice. Nothing here is a recommendation for either one; it’s meant to make the conversation with your provider easier.

Same Family, Different Personalities

Lexapro (escitalopram) and Prozac (fluoxetine) are both SSRIs, or selective serotonin reuptake inhibitors. Both are available as generics. Their FDA labels (Lexapro, Prozac) share most of the same warnings:

• The boxed warning about suicidal thoughts and behaviors in people up to age 24 (full wording in the comparison below).
• Serotonin syndrome, a rare but serious reaction, and a higher risk of bleeding, especially with aspirin, anti-inflammatory pain relievers or blood thinners.
• Setting off mania or hypomania in people with bipolar disorder.
• Low sodium, sexual side effects, and symptoms if stopped abruptly.

Neither can be taken with MAOIs (an older group of antidepressants) or with pimozide, and neither should be started in someone being treated with linezolid (an antibiotic) or intravenous methylene blue. Prozac’s label adds thioridazine, an older antipsychotic, to its list.

What Each Is FDA-Approved to Treat

For adults, the labels list:

• Lexapro (escitalopram): major depressive disorder and generalized anxiety disorder.
• Prozac (fluoxetine): major depressive disorder, OCD, panic disorder and bulimia nervosa. Taken together with olanzapine (an antipsychotic), it’s also approved for depressive episodes of bipolar I disorder and for treatment-resistant depression. Prozac on its own isn’t approved for either of those two. Both are also approved for some uses in children and teens, and those uses differ; we see adults 18 to 65.

So Prozac’s list is longer, while generalized anxiety disorder appears only on Lexapro’s. Bulimia nervosa is an eating disorder; it’s on Prozac’s label, which is a fact about the medication rather than a sign that it’s the right fit for everyone with that condition.

The approved list reflects what each manufacturer studied and submitted, not every condition a medication might help. Providers may prescribe an approved medication for another use when they judge it medically appropriate. This is called off-label use. Our anxiety disorders guide explains how generalized anxiety and panic disorder differ, and our OCD page covers how OCD is treated.

What Head-to-Head Research Shows

For depression, the big reviews point in slightly different directions, and none settles the question.

No clear difference overall. A review funded by the U.S. Agency for Healthcare Research and Quality, covering 234 studies of newer antidepressants, found no clinically relevant differences in how well they worked for depression. Its authors concluded that effectiveness alone isn’t a reason to favor one.

Some results lean toward escitalopram. The largest analysis, Cipriani and colleagues in 2018, an international study pooling 522 trials of 21 antidepressants, found that all of them beat placebo. In the head-to-head trials, escitalopram was listed among the more effective medications and fluoxetine among the less effective ones. Both were listed among the better tolerated, and fluoxetine was one of only two medications with fewer dropouts than placebo. A 2009 international Cochrane review found that response and remission were similar with escitalopram and fluoxetine; only a small difference in how much symptom scores fell favored escitalopram. It also warned that drug-company sponsorship could have inflated results.

How much weight these rankings can bear is debated. The Cipriani authors rated the certainty of their evidence as moderate to very low. A 2013 Cochrane review of fluoxetine, covering 171 studies, found some differences against other antidepressants but called their clinical meaning uncertain and said no definitive conclusions could be drawn. A 2019 reanalysis argued that the evidence behind antidepressant comparisons with placebo is weaker than the 2018 analysis suggested. That debate is about antidepressants in general, not about Lexapro compared with Prozac.

The fair summary is that any average difference between the two looks small, and averages can’t tell you how one person will respond.

The Biggest Practical Difference: How Long Each Stays in the Body

Half-life is the time it takes for the amount of a medication in the body to drop by half. This is where the two medications differ most.

• Lexapro: escitalopram’s half-life is about 27 to 32 hours, and its label says steady levels are reached in about a week.
• Prozac: fluoxetine’s half-life is about 4 to 6 days with ongoing use, and the liver turns it into norfluoxetine, an active form with a half-life of 4 to 16 days. The label says it takes several weeks for a dose change to show up fully in the blood, and that the medication persists in the body for weeks after the last dose.

That long tail has real effects, some helpful and some not.

Missed doses and stopping. In a 1998 U.S. trial, people doing well on fluoxetine, sertraline or paroxetine had their medication swapped for a placebo for 5 to 8 days without knowing it. Those on fluoxetine had fewer discontinuation symptoms than the other two groups. In another 1998 U.S. trial, stopping fluoxetine abruptly didn’t produce a cluster of discontinuation symptoms, and the authors suggested fluoxetine might suit people likely to miss doses. Escitalopram leaves the body faster. A 2024 international review listed it among the antidepressants linked to more frequent discontinuation symptoms, though results varied widely between studies, so drug-by-drug findings are preliminary. How common these symptoms are overall is still debated. Both labels recommend lowering the dose gradually rather than stopping abruptly whenever possible.

Switching. Because fluoxetine lingers, its label says to wait at least 5 weeks after stopping Prozac before starting an MAOI, compared with at least 14 days after stopping Lexapro. Thioridazine also has to wait at least 5 weeks after Prozac. When someone moves from Prozac to another medication, the two can overlap in the body for a while, which is one reason a switch is planned with your provider rather than done on your own.

Dose changes. With Prozac, the full effect of a change takes weeks to settle in, so adjustments tend to be judged over a longer stretch.

Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly. Our post on when to consider stopping medication explains how that decision is usually made.

Drug Interactions: Where They Differ Most

Both labels warn about combining either one with other serotonin-affecting medications, and with medications that affect bleeding. Beyond that, their interaction lists look quite different.

Prozac blocks liver enzymes, mainly CYP2D6, which clears many common medications, plus others such as CYP2C19. Its label says this can make a person with normal enzyme activity process those medications like someone whose enzyme works slowly. It calls for caution with certain antidepressants, antipsychotics and heart rhythm medications such as flecainide and propafenone. In two studies, levels of the older antidepressants imipramine and desipramine rose more than twofold to tenfold when fluoxetine was added, an effect that may persist for 3 weeks or longer after fluoxetine is stopped. Some medications cleared this way should be started at the low end of their dose range if fluoxetine was taken in the previous 5 weeks. The label also reports rising levels of the seizure medications phenytoin and carbamazepine, and changes in lithium levels. CYP2D6 also turns tamoxifen, a breast cancer medication, into its active form, and strong CYP2D6 blockers lower that active form; in a small international study, switching from fluoxetine or paroxetine to escitalopram raised it. If you take tamoxifen, tell your prescriber. The same enzyme activates codeine and tramadol, and their labels warn about CYP2D6 blockers.

Lexapro has a much shorter list. Its label says escitalopram is expected to have little effect on several major liver enzymes, with a modest effect on CYP2D6. In studies, it raised levels of desipramine and of metoprolol, a heart and blood pressure medication, and the label advises caution with medications cleared by CYP2D6. Because escitalopram is broken down by more than one enzyme, blocking a single one may not raise its levels much. Still, CYP2C19 matters: the label notes that people whose bodies clear escitalopram slowly (CYP2C19 poor metabolizers) reach higher levels. Pharmacogenetic testing can show how your body processes some medications; it doesn’t choose a medication for you.

For someone taking several medications, this difference can matter more than anything else in the comparison. Your pharmacist can check your full list against either one, including over-the-counter medicines and supplements.

The Heart Rhythm Question

QT is a stretch of the heartbeat measured on an electrocardiogram (ECG). A long QT interval can upset the timing of the heartbeat and cause sudden, fast rhythms. Here the labels and the research point in opposite directions.

• Prozac’s label has a QT item in its Warnings and Precautions section. It describes reports of QT prolongation and a dangerous rhythm called torsade de pointes after the medication went on the market, advises caution in people with risk factors such as long QT syndrome or a family history of sudden cardiac death, and suggests considering an ECG before starting and periodically in people with those risk factors. It says to avoid other medications known to prolong QT, and it lists CYP2D6 poor-metabolizer status and CYP2D6-blocking medicines among the risk factors, because they raise fluoxetine levels.
• Lexapro’s label has no QT item in its Warnings and Precautions section. It describes a small QT increase in a study of healthy volunteers, larger at a dose above the approved range, and notes that people who clear escitalopram slowly (CYP2C19 poor metabolizers) can reach similar levels at approved doses. It lists QT prolongation among reports after marketing.
• Both labels note that the medication hasn’t been well studied in people with a recent heart attack or unstable heart disease.

In the research, though, the QT signal is more consistent for escitalopram than for fluoxetine. A 2013 U.S. review of the published studies found possible dose-related QT prolongation with escitalopram, while fluoxetine at usual doses showed no clinically significant QT increase in most studies. A 2013 U.S. study of records from 38,397 adults linked higher doses of escitalopram to longer QT, but not fluoxetine. An international study of reports to the World Health Organization’s drug safety database found a QT signal for citalopram and escitalopram and none for fluoxetine in that study, while a 2025 analysis of the FDA’s adverse event database, also international, found a weaker signal for fluoxetine than for escitalopram. A 2026 analysis of trial data, an international study, found that escitalopram raised QT modestly compared with placebo, fluoxetine didn’t clearly do so, and antidepressants weren’t linked to early major heart problems. Apart from the trial analysis and the review, these were observational studies, so they can’t prove cause.

For most people the absolute risk is low, and it depends on the dose and on personal risk factors, such as other medications, a heart condition, or low potassium or magnesium. Fluoxetine’s effect on CYP2D6 also matters here, because some medications that affect QT are cleared by that enzyme. Tell your provider about any heart rhythm problem, fainting, a family history of long QT, and everything else you take.

Side Effects: Mostly Shared, a Few Differences

Most SSRI side effects overlap, and our post on common SSRI side effects goes through them. A few differences show up on the labels and in research:

• Feeling activated. Prozac’s label has a separate Warnings and Precautions item on anxiety and insomnia, and anxiety, nervousness and insomnia are on its list of most common side effects. Insomnia is on Lexapro’s most common list too, along with tiredness and sleepiness.
• Appetite and weight. Prozac’s label lists decreased appetite among its most common side effects and warns that weight loss can be a problem for people who are already underweight. In a 2024 study of 183,118 U.S. patients, escitalopram was linked to slightly more weight gain at 6 months than sertraline, under a pound on average, while fluoxetine was about the same as sertraline. The study was observational, and many patients stopped their medication along the way.
• Sexual side effects. Both labels warn about them and tell prescribers to ask directly, because patients don’t always bring them up. Prozac’s label adds that sexual symptoms occasionally persist after fluoxetine is stopped. We didn’t find a similar sentence in Lexapro’s current label, but that doesn’t make it unique to fluoxetine: lasting symptoms after stopping have been reported across SSRIs. We go further in sexual side effects of antidepressants.

People vary a great deal, and the side effect that bothers one person may never show up for another.

How Long Does Each Take to Work?

Roughly the same, based on what’s been studied. NIMH says antidepressants usually take 4 to 8 weeks to work, and that sleep, appetite, energy and concentration often improve before mood does. MedlinePlus says it may take 4 to 5 weeks or longer to feel the full benefit of fluoxetine and several weeks for escitalopram.

For OCD, NIMH notes that improvement can take 8 to 12 weeks to begin. Side effects often show up before the benefit does, and our post on feeling worse before you feel better walks through that stretch.

How the Choice Usually Gets Made

With no overall winner, the decision tends to rest on you rather than on a ranking:

• What’s being treated, and whether one label covers it and the other doesn’t.
• What you’ve taken before, and how it went.
• Everything else you take. Prozac’s interactions are broader and can last for weeks after stopping it.
• Your heart history, for the reasons above.
• How you’d handle stopping or switching later, since Prozac leaves the body slowly and Lexapro much faster.
• Age and liver health. For most older adults and for people with liver problems, Lexapro’s label recommends staying at the usual starting dose rather than going higher. Prozac’s label suggests considering a lower or less frequent dose for older adults, and using one for people with liver problems. Your provider will take that into account.
• Pregnancy or breastfeeding plans. Both labels discuss pregnancy risks, such as breathing and adjustment problems in newborns after exposure late in pregnancy, and bleeding after delivery, so plan with your provider. Both also report side effects in some infants exposed through breast milk. Our post on treating depression while breastfeeding has more.

Plenty of people need more than one try, and why finding the right medication can take time explains what usually comes next. For a closely related comparison, see Lexapro vs. Zoloft. We also compare Prozac vs. Zoloft. Our depression guide covers the bigger picture of treatment.

Looking for a psychiatrist in New Jersey? Our providers are board-certified psychiatric nurse practitioners (PMHNPs), who provide psychiatric evaluation and medication management. Choosing between medications like these is part of that conversation, before a first prescription and at every follow-up.

Frequently Asked Questions

Is Lexapro or Prozac better for anxiety?

Research doesn’t settle this. Lexapro is FDA-approved for generalized anxiety disorder, while Prozac is approved for panic disorder. Prozac’s label also lists anxiety and insomnia among its most common side effects. The answer turns on which anxiety condition you have, your past experience with medication and what else you take.

Is Prozac stronger than Lexapro?

Not in any meaningful way we can point to. The two come in different dose ranges, so the numbers on the bottle don’t tell you which is stronger. Large reviews haven’t shown a clinically important difference in how well they work, though some analyses lean slightly toward escitalopram.

Is it easier to stop Prozac than Lexapro?

Prozac leaves the body slowly, and studies have found fewer discontinuation symptoms after fluoxetine is interrupted or stopped. That doesn’t mean it can be stopped casually. Both labels recommend lowering the dose gradually whenever possible. Please don’t stop a medication on your own; some can cause withdrawal symptoms or a return of symptoms if stopped suddenly.

Can I switch from Prozac to Lexapro?

People do switch between SSRIs, and your provider can plan it with you. Because fluoxetine stays in the body for weeks, the two can overlap for a while, so the plan accounts for interactions and serotonin effects during that time.

Does Lexapro or Prozac cause more weight gain?

One large U.S. study found slightly more weight gain at 6 months with escitalopram than with sertraline, and about the same with fluoxetine as with sertraline. The differences were small, and individual results vary. Prozac’s label also notes decreased appetite and, in some people, weight loss.

Can you take Lexapro and Prozac together?

They aren’t usually combined. Lexapro’s label says using it with other SSRIs, SNRIs or tryptophan isn’t recommended, and combining serotonin-affecting medications raises the risk of serotonin syndrome.

If you’re deciding between these two, a psychiatric evaluation is a good place to begin, and medication management gives you regular follow-ups to adjust the plan as you go.

This article is for general educational purposes only. It does not constitute medical advice, does not establish a provider-patient relationship, and is not a substitute for individual evaluation, diagnosis, or treatment by a qualified clinician. If you’re in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline), any time, day or night. In an emergency, call 911 or go to the nearest emergency room.